Steven Cohen's LLY Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 7,119 shares of Eli Lilly and Company (LLY) worth $5.43 M, representing 0.01% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 40 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in LLY, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2015, adding 1.47 M shares. Largest reduction occurred in Q3 2016, reducing 1.04 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Eli Lilly and Company (LLY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Eli Lilly and Company (LLY) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2014 | +76,000 | New Buy | 76,000 | $68.99 |
| Q1 2015 | -76,000 | Sold Out | 0 | $0.00 |
| Q3 2015 | +1.47 M | New Buy | 1.47 M | $83.69 |
| Q4 2015 | -695,100 | Reduce 47.31% | 774,200 | $84.26 |
| Q1 2016 | +455,404 | Add 58.82% | 1.23 M | $72.01 |
| Q2 2016 | +120,676 | Add 9.81% | 1.35 M | $78.75 |
| Q3 2016 | -1.04 M | Reduce 77.16% | 308,400 | $80.26 |
| Q4 2016 | -301,500 | Reduce 97.76% | 6,900 | $73.48 |
| Q1 2017 | +895,700 | Add 12981.16% | 902,600 | $84.11 |
| Q2 2017 | +375,549 | Add 41.61% | 1.28 M | $82.30 |
| Q3 2017 | -678,149 | Reduce 53.06% | 600,000 | $85.54 |
| Q4 2017 | +46,800 | Add 7.80% | 646,800 | $84.46 |
| Q1 2018 | +251,891 | Add 38.94% | 898,691 | $77.37 |
| Q2 2018 | -152,891 | Reduce 17.01% | 745,800 | $85.33 |
| Q3 2018 | -695,800 | Reduce 93.30% | 50,000 | $107.32 |
| Q4 2018 | +268,673 | Add 537.35% | 318,673 | $115.72 |
| Q1 2019 | -318,673 | Sold Out | 0 | $0.00 |
| Q3 2019 | +906,761 | New Buy | 906,761 | $111.83 |
| Q4 2019 | -325,828 | Reduce 35.93% | 580,933 | $131.43 |
| Q1 2020 | -580,933 | Sold Out | 0 | $0.00 |
| Q3 2020 | +1.32 M | New Buy | 1.32 M | $148.02 |
| Q4 2020 | -479,441 | Reduce 36.42% | 837,100 | $168.84 |
| Q1 2021 | -837,100 | Sold Out | 0 | $0.00 |
| Q3 2021 | +87,100 | New Buy | 87,100 | $231.04 |
| Q4 2021 | +193,200 | Add 221.81% | 280,300 | $276.22 |
| Q1 2022 | -280,300 | Sold Out | 0 | $0.00 |
| Q2 2022 | +295,800 | New Buy | 295,800 | $324.23 |
| Q3 2022 | -6,645 | Reduce 2.25% | 289,155 | $323.35 |
| Q4 2022 | -289,155 | Sold Out | 0 | $0.00 |
| Q1 2023 | +4,425 | New Buy | 4,425 | $343.42 |
| Q2 2023 | +87,497 | Add 1977.33% | 91,922 | $468.98 |
| Q3 2023 | +90,706 | Add 98.68% | 182,628 | $537.13 |
| Q4 2023 | -11,417 | Reduce 6.25% | 171,211 | $582.92 |
| Q1 2024 | -45,301 | Reduce 26.46% | 125,910 | $777.96 |
| Q2 2024 | -125,910 | Sold Out | 0 | $0.00 |
| Q3 2024 | +13,158 | New Buy | 13,158 | $885.94 |
| Q4 2024 | -13,158 | Sold Out | 0 | $0.00 |
| Q1 2025 | +54,774 | New Buy | 54,774 | $825.91 |
| Q2 2025 | +133,736 | Add 244.16% | 188,510 | $779.53 |
| Q3 2025 | -181,391 | Reduce 96.22% | 7,119 | $762.96 |
Steven Cohen's Eli Lilly and Company Investment FAQs
Steven Cohen first purchased Eli Lilly and Company (LLY) in Q4 2014, acquiring 76,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Eli Lilly and Company (LLY) for 40 quarters since Q4 2014.
Steven Cohen's largest addition to Eli Lilly and Company (LLY) was in Q3 2015, adding 1,469,300 shares worth $122.97 M.
According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 7,119 shares of Eli Lilly and Company (LLY), valued at approximately $5.43 M.
As of the Q3 2025 filing, Eli Lilly and Company (LLY) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Eli Lilly and Company (LLY) was 1,469,300 shares, as reported at the end of Q3 2015.